Abstract Search

13.7. Vitamin D supplements for fracture prevention in schoolchildren in Mongolia: analysis of secondary outcomes from a multicentre, double-blind, randomised, placebo-controlled trial

D Ganmaa , P Khudyakov , U Buyanjargal , E Tserenkhuu , S Erdenenbaatar , CE Achtai , N Yansanjav , B Delgererekh , M Ankhbat , E Tsendjav , B Ochirbat , B Jargalsaikhan , D Enkhmaa , AR Martineau

Brief Summary: This multicenter, double-blind, randomized, placebo-controlled trial evaluated the effects of vitamin D supplementation (14,000 IU D3 weekly for 3 years) on fracture risk and other bone health indicators in 8,851 schoolchildren aged 613 years in 18 public schools in Mongolia, where vitamin D deficiency is highly prevalent with a high fracture burden.Vitamin D3 doses were given during weekly face-to-face visits in schools. Families co...

0 shares

ey0016.13-16 | Micronutrients | ESPEYB16

13.16. Global prevalence and disease burden of vitamin D deficiency: a roadmap for action in low- and middle-income countries

DE Roth , SA Abrams , J Aloia , G Bergeron , MW Bourassa , KH Brown , MS Calvo , KD Cashman , G Combs , LM De-Regil , ME Jefferds , KS Jones , H Kapner , AR Martineau , LM Neufeld , RL Schleicher , TD Thacher , SJ Whiting

Ann N Y Acad Sci. 2018 Oct;1430(1):4479. DOI: 10.1111/nyas.13968 This technical report reviews the global prevalence and public health disease burden of vitamin D deficiency. Funded by the Bill & Melinda Gates foundation, the working group of content experts from North America and Europe provide a roadmap outlining population-based strategies to impr...

0 shares

ESPE Yearbook of Paediatric Endocrinology

13.7. Vitamin D supplements for fracture prevention in schoolchildren in Mongolia: analysis of secondary outcomes from a multicentre, double-blind, randomised, placebo-controlled trial

13.16. Global prevalence and disease burden of vitamin D deficiency: a roadmap for action in low- and middle-income countries

BiosciAbstracts